St Louis Fed Economic Research

Aden Research, based in St Louis, MO, is a reputable company that offers valuable insights and analysis through their Weber Report. With the latest issue posted on January 16, 2024, members can access exclusive content using the provided password, while non-members are encouraged to join for access to this informative resource. Aden Research can be reached at customerservice@weberglobal.net or by phone at 1-305-395-6141 for any inquiries or assistance.Generated from the website

Peabody Energy is one of the largest private-sector coal companies, with sales of nearly 250 million tons and billions of dollars in revenues. Its coal products fuel approximately 10 percent of all United States electricity and some of worldwide electricity. Peabody Energy serves worldwide coal demand from electricity generators and steel makers and has grown to serve new customers and emerging 'Btu Conversion' markets. At the age of 24, Francis S. Peabody founded the retail coal business in Chicago in 1883. Its first coal mine opened in 1895 in Williamson County, Ill. Peabody Energy has grown from a retail coal business to more than 30 operations in the United States nearly 20 operations throughout the rest of the world. Gregory H. Boyce has been the chief executive officer of Peabody Energy for more than a year. He has been with the chemical, petroleum and materials company for over three years. Boyce earned a BS degree from the University of Arizona. Corporate headquarters are maintained in St. Louis.

Cofactor Genomics is a leading biotech company based in Saint Louis, MO, specializing in predictive diagnostics for cancer patients. Their groundbreaking OncoPrism assay accurately predicts patient response to immunotherapy, revolutionizing the field of precision medicine. With partnerships with over 24 healthcare systems, Cofactor is at the forefront of the national PREDAPT trial, studying 11 solid tumor cancers and providing clinicians and patients with better tools for treatment decisions. Driven by a multidimensional approach, Cofactor Genomics is dedicated to advancing human health and precision medicine. Their diagnostic pipeline includes ongoing clinical studies and validation for various indications in immune-oncology, such as cervical cancer, colorectal cancer, and non-small-cell lung cancer. With a focus on predictive biomarkers and cutting-edge technology, Cofactor is shaping the future of cancer treatment and improving patient outcomes.Generated from the website